by Team Small News | Mar 12, 2025 | Pharma, Torrent Pharma
The article discusses Torrent Pharmaceuticals’ (NSE:TORNTPHARM) ability to manage its debt with ease. The company has a debt-to-EBITDA ratio of 1.1, which is manageable, and its interest coverage ratio is a significant 12.3, indicating that the company has a...
by Team Small News | Mar 11, 2025 | Alkem, Lupin, Mankind, Pharma, Torrent Pharma
The cost of Empagliflozin, a crucial drug for managing diabetes and its associated conditions, is set to drop significantly in India. The price of the medicine, which was previously around Rs 60 per tablet, will be reduced to just Rs 9 per tablet, making it more...